Cargando…

Cortical Iron Reflects Severity of Alzheimer’s Disease

Abnormal iron distribution in the isocortex is increasingly recognized as an in vivo marker for Alzheimer’s disease (AD). However, the contribution of iron accumulation to the AD pathology is still poorly understood. In this study, we investigated: 1) frontal cortical iron distribution in AD and nor...

Descripción completa

Detalles Bibliográficos
Autores principales: van Duijn, Sara, Bulk, Marjolein, van Duinen, Sjoerd G., Nabuurs, Rob J.A., van Buchem, Mark A., van der Weerd, Louise, Natté, Remco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676973/
https://www.ncbi.nlm.nih.gov/pubmed/29081415
http://dx.doi.org/10.3233/JAD-161143
_version_ 1783277156034412544
author van Duijn, Sara
Bulk, Marjolein
van Duinen, Sjoerd G.
Nabuurs, Rob J.A.
van Buchem, Mark A.
van der Weerd, Louise
Natté, Remco
author_facet van Duijn, Sara
Bulk, Marjolein
van Duinen, Sjoerd G.
Nabuurs, Rob J.A.
van Buchem, Mark A.
van der Weerd, Louise
Natté, Remco
author_sort van Duijn, Sara
collection PubMed
description Abnormal iron distribution in the isocortex is increasingly recognized as an in vivo marker for Alzheimer’s disease (AD). However, the contribution of iron accumulation to the AD pathology is still poorly understood. In this study, we investigated: 1) frontal cortical iron distribution in AD and normal aging and 2) the relation between iron distribution and degree of AD pathology. We used formalin fixed paraffin embedded frontal cortex from 10 AD patients, 10 elder, 10 middle aged, and 10 young controls and visualized iron with a modified Perl’s histochemical procedure. AD and elderly subjects were not different with respect to age and sex distribution. Iron distribution in the frontal cortex was not affected by normal aging but was clearly different between AD and controls. AD showed accumulation of iron in plaques, activated microglia, and, in the most severe cases, in the mid-cortical layers along myelinated fibers. The degree of altered iron accumulations was correlated to the amount of amyloid-β plaques and tau pathology in the same block, as well as to Braak stage (p < 0.001). AD and normal aging show different iron and myelin distribution in frontal cortex. These changes appear to occur after the development of the AD pathological hallmarks. These findings may help the interpretation of high resolution in vivo MRI and suggest the potential of using changes in iron-based MRI contrast to indirectly determine the degree of AD pathology in the frontal cortex.
format Online
Article
Text
id pubmed-5676973
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-56769732017-11-16 Cortical Iron Reflects Severity of Alzheimer’s Disease van Duijn, Sara Bulk, Marjolein van Duinen, Sjoerd G. Nabuurs, Rob J.A. van Buchem, Mark A. van der Weerd, Louise Natté, Remco J Alzheimers Dis Research Article Abnormal iron distribution in the isocortex is increasingly recognized as an in vivo marker for Alzheimer’s disease (AD). However, the contribution of iron accumulation to the AD pathology is still poorly understood. In this study, we investigated: 1) frontal cortical iron distribution in AD and normal aging and 2) the relation between iron distribution and degree of AD pathology. We used formalin fixed paraffin embedded frontal cortex from 10 AD patients, 10 elder, 10 middle aged, and 10 young controls and visualized iron with a modified Perl’s histochemical procedure. AD and elderly subjects were not different with respect to age and sex distribution. Iron distribution in the frontal cortex was not affected by normal aging but was clearly different between AD and controls. AD showed accumulation of iron in plaques, activated microglia, and, in the most severe cases, in the mid-cortical layers along myelinated fibers. The degree of altered iron accumulations was correlated to the amount of amyloid-β plaques and tau pathology in the same block, as well as to Braak stage (p < 0.001). AD and normal aging show different iron and myelin distribution in frontal cortex. These changes appear to occur after the development of the AD pathological hallmarks. These findings may help the interpretation of high resolution in vivo MRI and suggest the potential of using changes in iron-based MRI contrast to indirectly determine the degree of AD pathology in the frontal cortex. IOS Press 2017-11-07 /pmc/articles/PMC5676973/ /pubmed/29081415 http://dx.doi.org/10.3233/JAD-161143 Text en © 2017 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
van Duijn, Sara
Bulk, Marjolein
van Duinen, Sjoerd G.
Nabuurs, Rob J.A.
van Buchem, Mark A.
van der Weerd, Louise
Natté, Remco
Cortical Iron Reflects Severity of Alzheimer’s Disease
title Cortical Iron Reflects Severity of Alzheimer’s Disease
title_full Cortical Iron Reflects Severity of Alzheimer’s Disease
title_fullStr Cortical Iron Reflects Severity of Alzheimer’s Disease
title_full_unstemmed Cortical Iron Reflects Severity of Alzheimer’s Disease
title_short Cortical Iron Reflects Severity of Alzheimer’s Disease
title_sort cortical iron reflects severity of alzheimer’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676973/
https://www.ncbi.nlm.nih.gov/pubmed/29081415
http://dx.doi.org/10.3233/JAD-161143
work_keys_str_mv AT vanduijnsara corticalironreflectsseverityofalzheimersdisease
AT bulkmarjolein corticalironreflectsseverityofalzheimersdisease
AT vanduinensjoerdg corticalironreflectsseverityofalzheimersdisease
AT nabuursrobja corticalironreflectsseverityofalzheimersdisease
AT vanbuchemmarka corticalironreflectsseverityofalzheimersdisease
AT vanderweerdlouise corticalironreflectsseverityofalzheimersdisease
AT natteremco corticalironreflectsseverityofalzheimersdisease